These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20186939)

  • 21. Clinical challenges and images in GI. Oral lichenoid reaction in a patient with Crohn's disease receiving infliximab.
    Moss AC; Treister NS; Marsee DK; Cheifetz AS
    Gastroenterology; 2007 Feb; 132(2):488, 829. PubMed ID: 17261307
    [No Abstract]   [Full Text] [Related]  

  • 22. The cost-effectiveness of infliximab in Crohn's disease.
    Smart C; Selinger CP
    Expert Rev Pharmacoecon Outcomes Res; 2014 Oct; 14(5):589-98. PubMed ID: 25138162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Indications and results of infliximab in Crohn's disease].
    Karoui S; Boubaker J; Filali A
    Tunis Med; 2004 Dec; 82(12):1057-63. PubMed ID: 15822505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffuse alveolar hemorrhage after infliximab treatment of Crohn's disease.
    Panagi S; Palka W; Korelitz BI; Taskin M; Lessnau KD
    Inflamm Bowel Dis; 2004 May; 10(3):274-7. PubMed ID: 15290924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness and tolerability of repeated treatment with infliximab in patients with Crohn's disease: a retrospective data analysis in Germany.
    Witthöft T; Ludwig D
    Int J Colorectal Dis; 2005 Jan; 20(1):18-23. PubMed ID: 15459773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infliximab induced liver injury in Crohn's disease: a challenging diagnosis.
    Carvalheiro J; Mendes S; Sofia C
    J Crohns Colitis; 2014 May; 8(5):436-7. PubMed ID: 24291019
    [No Abstract]   [Full Text] [Related]  

  • 27. Extra-intestinal Hodgkin's lymphoma in a Crohn's disease patient on long-term azathioprine and infliximab therapy.
    Dahhan T; Al Kahtani K; Bakshi N; Abouzied ME; Helmy A
    Trop Gastroenterol; 2010; 31(1):51-3. PubMed ID: 20860231
    [No Abstract]   [Full Text] [Related]  

  • 28. Adalimumab-induced lupus erythematosus in Crohn's disease patients previously treated with infliximab.
    Mañosa M; Domènech E; Marín L; Olivé A; Zabana Y; Cabré E; Gassull MA
    Gut; 2008 Apr; 57(4):559; author reply 559-60. PubMed ID: 18334664
    [No Abstract]   [Full Text] [Related]  

  • 29. [Pneumocystis pneumonia during infliximab treatment for active Crohn's colitis].
    Minnee RC; Stokkers P; Riemens SC; Hommes DW
    Ned Tijdschr Geneeskd; 2005 Oct; 149(41):2290-5. PubMed ID: 16240855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between infliximab treatment and lymphoma in Crohn's disease.
    Bickston SJ; Lichtenstein GR; Arseneau KO; Cohen RB; Cominelli F
    Gastroenterology; 1999 Dec; 117(6):1433-7. PubMed ID: 10579985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exacerbation of Mycobacterium tuberculosis enteritis masquerading as Crohn's disease after treatment with a tumor necrosis factor-alpha inhibitor.
    Wagner TE; Huseby ES; Huseby JS
    Am J Med; 2002 Jan; 112(1):67-9. PubMed ID: 11812409
    [No Abstract]   [Full Text] [Related]  

  • 32. Infliximab and Crohn's QOL.
    Wicks AC; Thomas C; Curran R; Mayberry JF
    Aliment Pharmacol Ther; 2002 Oct; 16(10):1831-2. PubMed ID: 12269979
    [No Abstract]   [Full Text] [Related]  

  • 33. Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. CON: "lifetime use" is an awfully long time.
    Loftus EV
    Am J Gastroenterol; 2005 Jul; 100(7):1435-8. PubMed ID: 15984960
    [No Abstract]   [Full Text] [Related]  

  • 34. Severe leptospirosis in a Dutch traveller returning from the Dominican Republic, October 2011.
    Arcilla M; Wismans PJ; van Beek-Nieuwland Y; van Genderen PJ
    Euro Surveill; 2012 Mar; 17(13):. PubMed ID: 22490382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A case of acute and necrotizing cutaneous Mycobacterium marinum infection in a patient treated with infliximab for Crohn's disease].
    Guyot A; Begon E; Abramowitz L; Landry J; Marinho E; Descamps V; Crickx B
    Ann Dermatol Venereol; 2009 Nov; 136(11):806-10. PubMed ID: 19917434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peripheral neuropathy with infliximab therapy in inflammatory bowel disease.
    Burger DC; Florin TH
    Inflamm Bowel Dis; 2009 Dec; 15(12):1772. PubMed ID: 19170193
    [No Abstract]   [Full Text] [Related]  

  • 37. Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. PRO: maintenance therapy is superior to episodic therapy.
    Lichtenstein GR
    Am J Gastroenterol; 2005 Jul; 100(7):1433-5. PubMed ID: 15984959
    [No Abstract]   [Full Text] [Related]  

  • 38. [Infliximab in the treatment of Crohn's disease -- a practical approach. Infliximab and chronic Crohn's disease--Consensus statement of the Working Group on Chronic Inflammatory Crohn's Diseases of the OGGH].
    Tilg H; Knoflach P; Petritsch W; Vogelsang H; Reinisch W;
    Z Gastroenterol; 2004 Oct; 42(10):1256-63. PubMed ID: 15508068
    [No Abstract]   [Full Text] [Related]  

  • 39. Ileocolonic tuberculosis clinically, endoscopically, and radiologically mimicking Crohn's disease: disseminated infection after treatment with infliximab.
    Cappell MS; Saad A; Bortman JS; Amin M
    J Crohns Colitis; 2014 Jun; 8(6):560-2. PubMed ID: 24360259
    [No Abstract]   [Full Text] [Related]  

  • 40. Infliximab therapy for Crohn's disease in a patient with chronic hepatitis B.
    Ueno Y; Tanaka S; Shimamoto M; Miyanaka Y; Hiyama T; Ito M; Kitadai Y; Yoshihara M; Sumii M; Chayama K
    Dig Dis Sci; 2005 Jan; 50(1):163-6. PubMed ID: 15712655
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.